Previous Article | Next Article 
Journal of Virology, April 1999, p. 2963-2973, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Reovirus Virion-Like Particles Obtained by Recoating Infectious
Subvirion Particles with Baculovirus-Expressed
3 Protein: an
Approach for Analyzing
3 Functions during Virus Entry
Judit
Jané-Valbuena,1,2
Max
L.
Nibert,1,2,*
Stephan
M.
Spencer,1,2
Stephen B.
Walker,3
Timothy S.
Baker,3
Ya
Chen,4
Victoria E.
Centonze,4 and
Leslie
A.
Schiff5
Department of Biochemistry, College of
Agricultural and Life Sciences,1 and
Institute for Molecular Virology2 and
Integrated Microscopy Resource,4 The
Graduate School, University of Wisconsin
Madison, Madison, Wisconsin
53706; Department of Biological Sciences, Purdue University,
West Lafayette, Indiana 479073; and
Department of Microbiology, University of Minnesota Medical
School, Minneapolis, Minnesota 554555
Received 20 August 1998/Accepted 8 December 1998
 |
ABSTRACT |
Structure-function studies with mammalian reoviruses have been
limited by the lack of a reverse-genetic system for engineering mutations into the viral genome. To circumvent this limitation in a
partial way for the major outer-capsid protein
3, we obtained in
vitro assembly of large numbers of virion-like particles by binding
baculovirus-expressed
3 protein to infectious subvirion particles
(ISVPs) that lack
3. A level of
3 binding approaching 100% of
that in native virions was routinely achieved. The
3 coat in these
recoated ISVPs (rcISVPs) appeared very similar to that in virions by
electron microscopy and three-dimensional image reconstruction. rcISVPs
retained full infectivity in murine L cells, allowing their use to
study
3 functions in virus entry. Upon infection, rcISVPs behaved
identically to virions in showing an extended lag phase prior to
exponential growth and in being inhibited from entering cells by either
the weak base NH4Cl or the cysteine proteinase inhibitor
E-64. rcISVPs also mimicked virions in being incapable of in vitro
activation to mediate lysis of erythrocytes and transcription of the
viral mRNAs. Last, rcISVPs behaved like virions in showing minor loss
of infectivity at 52°C. Since rcISVPs contain virion-like levels of
3 but contain outer-capsid protein µ1/µ1C mostly cleaved at the
-
junction as in ISVPs, the fact that rcISVPs behaved like
virions (and not ISVPs) in all of the assays that we performed suggests
that
3, and not the
-
cleavage of µ1/µ1C, determines the
observed differences in behavior between virions and ISVPs. To
demonstrate the applicability of rcISVPs for genetic studies of protein
functions in reovirus entry (an approach that we call recoating
genetics), we used chimeric
3 proteins to localize the primary
determinants of a strain-dependent difference in
3 cleavage rate to
a carboxy-terminal region of the ISVP-bound protein.
 |
INTRODUCTION |
Mammalian orthoreoviruses
(reoviruses) serve as useful models to study the viral and cellular
determinants that enable nonenveloped viruses to enter cells and
initiate infection. The mature reovirus virion comprises two concentric
icosahedral capsids, which in turn surround the segmented
double-stranded RNA genome. Outer-capsid proteins
1,
3, and
µ1/µ1C play critical roles in virus entry. The first step in entry,
binding to cell surface receptors, is mediated by the
1 trimer
located at each fivefold axis in virions (24, 26, 49).
Following receptor binding, reovirus virions are delivered into
endocytic compartments, where they undergo partial uncoating. By this
process the major outer-capsid proteins
3 and µ1/µ1C, present in
600 copies each, are proteolytically cleaved, yielding subvirion
particles (16, 48) with similarities to the infectious
subvirion particles (ISVPs) that can be generated by in vitro
proteolysis (7, 30, 45). Notable features of these subvirion
particles include loss of
3 and cleavage of µ1/µ1C within a
defined region near its C terminus to generate particle-bound fragments
µ1
/
and
(40). Subsequent to the required
cleavages of
3 and/or µ1/µ1C, the µ1/µ1C protein is thought
to undergo a change in conformation analogous to those by the fusion
proteins of enveloped viruses, giving it the capacity to perturb the
integrity of the adjacent membrane bilayer (9, 14, 15, 27, 35, 39,
52). This interaction provides access to the cytoplasm for the
resulting subvirion particle in which the particle-associated enzymes
for transcription of the viral mRNAs are activated from their
latent state in virions (8, 10, 14, 19, 22, 30, 45).
Although proteolysis of outer-capsid proteins is essential for
productive infections (see below), the molecular basis for this
requirement remains to be fully characterized. In nature, reoviruses
infect via the enteric and respiratory tracts. Studies with proteinase
inhibitors have shown that in the intestinal tract, proteolysis of
outer-capsid proteins by pancreatic serine proteinases, generating
ISVP-like subvirion particles, is required for at least some reovirus
strains to adhere to M cells and infect intestinal target tissues
(1, 6). In contrast, when reoviruses infect via the
respiratory tract, where the concentration of extracellular proteinases
is low, proteolysis more likely occurs after uptake of virions into the
acidic endocytotic compartments of target cells. Studies with cultured
cell lines have clearly demonstrated the need for intracellular
proteolysis during infections with intact reovirus virions. In culture,
infections with virions, but not ISVPs, can be blocked by treating
cells with weak bases like NH4+ (e.g., from
NH4Cl) that raise pH in acidic compartments in cells, including endosomes and lysosomes (3, 12, 50). Similar results are obtained with E-64, an inhibitor of papain family cysteine
proteinases, including several that reside in mammalian lysosomes
(3, 15). Treatment with pepstatin A, an inhibitor of
aspartic proteinases including cathepsin D in mammalian lysosomes, however, has no effect on reovirus infections (32).
Together, these data indicate that specific cellular proteinases
participate in cleaving
3 and/or µ1/µ1C during entry into cells.
Recent evidence indicates that the effects of E-64 and
NH4Cl on reovirus infections can be overcome by infecting
cells either with ISVPs (3, 50) or with dpSVPs, distinct
subvirion particles which are like ISVPs in lacking
3 but like
virions in having very few µ1/µ1C molecules cleaved at the
-
junction (15). The latter finding suggests that cleavage of
µ1/µ1C at the
-
junction during reovirus entry is dispensable
for infection and that only cleavages of
3 are required. Many
molecular details of reovirus entry, including which cleavages of
3
are needed to activate the membrane-disrupting potential of the
underlying µ1/µ1C protein and which host proteinases effect these
cleavages, remain to be determined.
To understand the molecular basis of reovirus entry in greater detail,
we sought to develop a system in which the
3 protein could be
altered (e.g., by site-directed mutagenesis) and assembled into
virion-like particles, after which the consequences of these mutations
on virion structure and entry into cells could be analyzed. Chang and
Zweerink (16) provided the first evidence that
3 protein
derived from reovirus-infected L cells can bind to ISVP-like subvirion
particles generated during reovirus infection. Subsequent studies by
Astell et al. (2) showed that the reassembled particles obtained in this manner are similar to native virions in density, appearance in electron micrographs, and insensitivity to transcriptase activation. Recent work in one of our laboratories showed that
3
generated by in vitro transcription-translation, using a
3-encoding S4 cDNA (31), can bind to purified ISVPs and remain bound
through purification in a CsCl gradient (46). Moreover, the
conformation of the
3 molecules bound to ISVPs appeared identical to
that bound to virions, based on an identical pattern of
3 cleavage fragments following limited in vitro digestion with proteinase K
(46).
Although in vitro transcription-translation generates sufficient
amounts of
3 for many types of analytical studies with recoated particles (46), that approach is not conducive to obtaining large numbers of virion-like particles. Here, we demonstrate that this
limitation can be overcome by using
3 protein from lysates of insect
cells that are infected with a recombinant baculovirus providing high
levels of
3 expression. Using baculovirus-expressed
3 protein, we
approximated stoichiometric recoating of large numbers of ISVPs and
performed studies which indicate that these recoated ISVPs (rcISVPs)
mimic both the appearance and the behavior of virions in several
respects. We conclude from these studies that
3, and not the
-
cleavage of µ1/µ1C, is the primary determinant of structural and
functional differences between virions and ISVPs. Since virion-like
particles can be similarly reconstituted with
3 mutants
(29), we can now explore the roles of
3 in reovirus entry
by using an approach that we call recoating genetics. To demonstrate
this approach, we used chimeric
3 proteins to localize the primary
determinants of a strain-dependent difference in
3 cleavage rate to
a C-terminal region of the ISVP-bound protein.
 |
MATERIALS AND METHODS |
Cells.
Spinner-adapted L cells were grown in Joklik's
modified minimal essential medium (Irvine Scientific Co., Irvine,
Calif.) supplemented to contain 2% fetal bovine serum, 2% neonatal
bovine serum (HyClone Laboratories, Logan, Utah), 2 mM glutamine, 100 U
of penicillin per ml, and 100 µg of streptomycin per ml (Irvine
Scientific). Spodoptera frugiperda clone 21 (Sf21) insect
cells (Invitrogen, Carlsbad, Calif.) were grown in TC-100 medium (Gibco
BRL, Gaithersburg, Md.) supplemented to contain 10% heat-inactivated
fetal bovine serum.
Recombinant baculovirus containing the reovirus T3D S4 gene.
A cDNA copy of the reovirus type 3 Dearing (T3D) S4 gene
(31) was subcloned into the EcoRI site of the
transfer plasmid pEV/35K/ polybsmcr (34) under
transcriptional control of the baculovirus polyhedrin promoter.
Recombinant baculoviruses containing the polyhedrin-S4 construct
(termed S4D-baculoviruses) were then obtained and amplified as
described for the reovirus S3 gene (25). Expression of the
T3D
3 protein upon infection of Sf21 cells with S4D-baculoviruses
was confirmed by sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE) and immunoblotting.
Expression of
3 in insect cells.
Sf21 cells (5 × 106) were infected with S4D-baculovirus at 10 PFU/cell.
Cells were harvested at 48 h postinfection, washed with
phosphate-buffered saline (PBS: 137 mM NaCl, 8.1 mM
Na2HPO4, 2.7 mM KCl, 1.5 mM
KH2PO4 [pH 7.5]), and lysed with 800 µl of lysis buffer (20 mM Tris, 5 mM MgCl2, 1% Triton X-100, 0.1 M NaCl, 5 µg of leupeptin per ml, 1 mM phenylmethylsulfonyl fluoride
[pH 7.4]) by incubation on ice for 30 min. Immediately after
incubation, the lysed cells were pelleted by centrifugation at
500 × g for 10 min at 4°C. The soluble (cytoplasmic)
fraction was removed, and the pellet was resuspended in 800 µl of PBS
adjusted to contain 500 mM NaCl. After centrifugation at
22,000 × g for 10 min, the new soluble fraction
(nuclear lysate), which contained most of the
3 protein, was harvested.
Virions and ISVPs.
Virions of reovirus type 1 Lang (T1L) or
T3D were obtained by the standard protocol (24) and stored
in virion buffer (150 mM NaCl, 10 mM MgCl2, 10 mM Tris [pH
7.5]). To obtain T1L ISVPs, the same protocol was followed except that
after the second freon extraction, virions were diluted in virion
buffer and pelleted by centrifugation at 5°C in an SW28 rotor
(Beckman Instruments, Palo Alto, Calif.) spun at 25,000 rpm for 2 h. The pelleted virions were resuspended in virion buffer at a
concentration lower than 1013 particles/ml and treated with
200 µg of N
-p-tosyl-L-lysine chloromethyl ketone (TLCK)-treated
-chymotrypsin (CHT) (Sigma Chemical Co., St.
Louis, Mo.) per ml for 50 min at 37°C. ISVPs were purified by
centrifugation in a preformed CsCl gradient (24) and stored in virion buffer after dialysis. All particle concentrations were determined from A260 (17).
rcISVPs.
Purified T1L ISVPs were incubated at room
temperature for 30 min with nuclear lysate derived from Sf21 cells
infected with S4D-baculovirus. Stoichiometric recoating was routinely
achieved by adding lysate from 5 × 106 infected cells
to 2.5 × 1012 ISVPs. Virion buffer was added to
decrease the NaCl concentration of the final mixture to 250 to 350 mM.
Immediately after incubation, the sample was layered on a preformed
CsCl density gradient (1.27 to 1.46 g/cm3) and subjected to
centrifugation at 5°C in an SW41 rotor (Beckman) spun at 35,000 rpm
for at least 4 h. The particle band was harvested and dialyzed
into virion buffer. Particle concentration was determined from
A260 values, using the conversion factor
corresponding to virions (17).
SDS-PAGE and immunoblotting.
Samples to be analyzed by
SDS-PAGE were diluted 2:1 with 3× sample buffer (375 mM Tris, 30%
sucrose, 3% SDS, 6%
-mercaptoethanol, 0.03% bromophenol blue [pH
8.0]) and boiled for 1 to 2 min. Ten percent acrylamide gels were
used, and proteins were visualized by staining with Coomassie brilliant
blue R-250 (Sigma). For immunoblots, protein samples were subjected to
SDS-PAGE and transferred to nitrocellulose at 4°C overnight at 30 V
in transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol [pH
8.3]). Mouse-derived,
3-specific monoclonal antibody 4F2
(53) was used at a 1/2,000 dilution of a 1-mg/ml stock.
Detection of this antibody was achieved by using 1/3,000 alkaline
phosphatase-coupled goat anti-mouse immunoglobulin (Bio-Rad
Laboratories, Hercules, Calif.) with 300 µg of p-nitroblue
tetrazolium chloride per ml and 150 µg of 5-bromo-4-chloro-3-indolyl phosphate p-toluidine per ml (Bio-Rad) in substrate buffer
(100 mM Tris, 0.5 mM MgCl2 [pH 9.5]).
Buoyant densities.
Particles (2 × 1011)
were layered on a 10-ml 1.30- to 1.46-g/cm3 preformed CsCl
gradient and subjected to centrifugation at 5°C in an SW41 rotor
(Beckman) spun at 25,000 rpm for 12 to 16 h. Gradients were
fractionated into 300-µl aliquots by collection from bottom to top,
using a peristaltic pump (Rainin Instrument Co., Woburn, Mass.).
Fractions containing virus particles were located by measuring
A260, and buoyant densities of the peak
fractions were determined by measuring refractive indices with a
digital refractometer (Bausch & Lomb, Rochester, N.Y.).
Electron microscopy and 3-D image reconstruction.
Fresh
rcISVPs samples were prepared for conventional transmission electron
microscopy (TEM) as described previously (13). Samples of
freshly generated rcISVPs were prepared for low-temperature, high-resolution scanning electron microscopy (cryo-SEM) and viewed as
described previously (13). Images were acquired in digital format directly from the microscope by using Digital Micrograph (Gatan), and their brightness and contrast were optimized by using Photoshop (Adobe Systems, Mountain View, Calif.). For low-temperature, high-resolution TEM (cryo-TEM), purified rcISVPs were embedded in
vitreous ice, and micrographs were recorded at a nominal magnification of ×38,000, using standard low-dose cryo-TEM procedures on a Philips CM200 microscope (5). Ninety-one particles were selected
from three micrographs (defocus values of 2.1, 2.6, and 3.3 µm) and analyzed with image processing techniques for icosahedral particles (4, 23). The particle orientations were evenly distributed throughout the asymmetric unit, as evidenced by all inverse eigenvalues being <1.0 and at least 99% being <0.1 (23). The final
three-dimensional (3-D) reconstruction was calculated at 33-Å resolution.
Plaque assays.
Plaque assays to determine particle/PFU
ratios of reovirus preparations were done as described previously
(24). To determine infectious titers in other experiments, a
modified procedure was used. Prior to addition of virus, the monolayers
were washed to remove serum with PBS plus 2 mM MgCl2. After
a 1-h attachment period, the monolayers were covered with 2 ml of 1%
Bacto Agar and serum-free medium 199 containing 10 µg of trypsin per
ml (Sigma). Plaques were counted 2 days later.
Infectivity experiments.
Single-step growth curves were
determined as described elsewhere (15). Endpoint experiments
with NH4Cl were performed as for single-step growth curves
except that only 0- and 24-h time point samples were harvested and 20 mM NH4Cl was included in the culture medium. Endpoint
experiments with E-64 (Sigma) and pepstatin A (Sigma) were performed as
follows. L cells at 4 × 105 cells/ml were dispensed
in 2-dram vials and pretreated for 2 h at 37°C with 300 µM
E-64 or 30 µM pepstatin A (each dissolved in dimethyl sulfoxide), or
with dimethyl sulfoxide alone (for samples without inhibitor). After
pretreatment, cells were chilled at 4°C for
15 min, the growth
medium was removed, and virus particles were added at 3 PFU/cell.
Adsorption proceeded for 1 h at 4°C, after which the inoculum
was removed, and the original medium (with or without inhibitor) was
added back to each vial. Vials were then transferred to a 37°C
incubator, and 0- and 24-h time point samples were harvested by freezing.
Hemolysis and transcription.
The capacity of reovirus
particles to lyse erythrocytes was measured by a spectrophotometric
assay for hemoglobin release (15, 39). The capacity of
reovirus particles to mediate transcription of the viral mRNAs in vitro
was measured by a radiometric assay for incorporation of
[
-32P]GTP into acid-precipitable material
(36).
Heat inactivation.
Viral particles at a concentration of
4 × 107 particles/ml in 500 µl of virion buffer
were incubated at 52°C for 1 h or were kept on ice as a control.
Heat treatment was ended by transferring the 52°C samples onto ice,
and infectious titers were determined for all samples by plaque assay.
The decrease in infectivity due to heat inactivation was expressed as
the difference between the log10 titers of each
heat-treated sample and the corresponding control sample.
Construction of T1L and T3D
3 chimeras.
DNA clones of the
T1L and T3D S4 genes, inserted into pBluescript KS+
(Stratagene, La Jolla, Calif.) at the EcoRI site, were
cleaved with BsaI and StyI (both within the S4
gene) or with StyI and EcoRV (the latter within
the vector beyond the 3' end of the S4 plus strand) to obtain middle
(S4 nucleotides 552 to 791, corresponding to
3 amino acids 186 to
265) or C-terminal (S4 nucleotides 792 to 1095, corresponding to
3
amino acids 266 to 365) fragments of S4, respectively. These fragments
were exchanged between the T1L and T3D S4 constructs to generate
chimeras as shown in Fig. 10A. The chimeric S4 genes were subcloned
into the pEV/35K/polybsmcr plasmid (34), and the resulting
constructs were used to express each
3 protein in insect cells by
using a novel baculovirus system (28). Protein was labeled
at 40 h postinfection with 25 µCi of
[35S]methionine/cysteine per ml, and 8 h later cells
were harvested as described above.
 |
RESULTS |
Expression of recombinant
3 protein in insect cells.
To
obtain high levels of
3 expression for stoichiometric recoating of
ISVPs, we constructed a recombinant baculovirus containing a cDNA copy
of the S4 gene from reovirus T3D under control of the baculovirus
polyhedrin promoter. At 48 h after infection with the recombinant
baculovirus, insect cells were harvested and lysed. This treatment,
followed by centrifugation at 500 × g, rendered a
soluble supernatant (cytoplasmic fraction) and a pellet containing nuclei and insoluble material. SDS-PAGE and immunoblot analyses of
these two fractions (Fig. 1 and data not
shown) confirmed high levels of
3 expression and revealed that most
3 was in the pellet. This distribution could indicate either that
3 was insoluble or that it had been localized to the nucleus in
insect cells as previously observed for
3 expressed in HeLa cells
from an S4 cDNA (56) and in L cells after reovirus T3D
infection (43). To distinguish between these possibilities,
we resuspended the pellet and disrupted the nuclei with a series of
buffers containing increasing amounts of salt. After centrifugation at
22,000 × g, SDS-PAGE of each new supernatant (nuclear
lysate) and pellet fraction demonstrated recovery of
3 in the
supernatant, with more
3 protein recovered at higher salt
concentrations (data not shown). These findings suggest that
3 was
recovered in the initial pellet because of its localization to the
nucleus in insect cells. In subsequent experiments, buffer containing
0.5 M NaCl was used to release
3 from the pellet (as shown in Fig.
1) since higher concentrations did not improve recovery and were a
concern for binding experiments.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 1.
Expression of 3 in insect cells by using recombinant
S4D-baculovirus. (A) Cytoplasmic (cyt) and nuclear lysate (nuc)
fractions from Sf21 cells infected with LacZ-baculovirus (lanes 1 and
2) or S4D-baculovirus (lanes 3 and 4) were subjected to SDS-PAGE and
Coomassie blue staining. A sample of reovirus T3D virions (vir; lane 5)
was included to give a size marker for 3. The positions of
-galactosidase ( -gal) and 3 proteins are indicated by arrows.
Molecular weight markers (sizes in kilodaltons) are indicated at the
left. (B) The lysate fractions analyzed in panel A were subjected to
SDS-PAGE followed by immunoblot analysis using 3-specific monoclonal
antibody 4F2 (53). The origin and significance of the
high-molecular-weight band in lane 5 of panel B remain unconfirmed;
however, this band is likely to represent a dimeric form of 3 that
resists disruption in preparation for electrophoresis. This form of
3 may arise during particle preparation and/or storage since it is
seen only with purified particles (also see Fig. 2B, lanes 1 and 3).
|
|
Stoichiometric recoating of ISVPs with recombinant
3.
To
determine if baculovirus-expressed T3D
3 protein can bind to ISVPs,
purified ISVPs of reovirus T1L (generated from virions by in vitro CHT
digestion and chosen over T3D ISVPs for their greater stability) were
incubated with nuclear lysate from
3-expressing insect cells. After
incubation, the particles were subjected to centrifugation in a
preformed CsCl gradient to separate soluble
3 from any that was
particle associated. SDS-PAGE and immunoblot analyses revealed that
3 had bound to the particles and remained bound through
centrifugation (Fig. 2). Different ratios
of
3-containing lysate and ISVPs led to different extents of
3
binding (data not shown). With excess lysate, however, the amount of
bound
3 appeared to approximate that present in virions (Fig. 2),
suggesting that nearly all potential binding sites for
3 had been
occupied. To quantify the extent of recoating, SDS-PAGE followed by
Coomassie blue staining and densitometry was performed with both native virions and ISVPs that appeared to have been fully recoated with
3.
For each sample, the intensity of the
3 band was expressed relative
to that of the
-protein band. Comparison of
3/
ratios indicated that the
3 content of the recoated particles was
equivalent to that of virions (Table 1),
consistent with stoichiometric recoating.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 2.
SDS-PAGE and immunoblot analysis of rcISVPs. T1L ISVPs
(2.5 × 1012) were incubated with the nuclear fraction
from 5 × 106 Sf21 cells infected with
S4D-baculovirus. rcISVPs were purified by centrifugation through a CsCl
density gradient and dialyzed extensively against virion buffer.
Virions (lane 1), ISVPs (lane 2), and rcISVPs (lane 3) (5 × 1010 each) were subjected to SDS-PAGE and Coomassie blue
staining (A) or immunoblotting with the 3 monoclonal antibody 4F2
(53) (B).
|
|
Measurements of buoyant density were made to obtain additional evidence
that complete recoating of ISVPs had been approximated
with
baculovirus-expressed

3. Virions and ISVPs contain the same
complement of nucleic acids, but virions have a higher protein
content
due to the presence of

3 and thus exhibit a buoyant density
in CsCl
(1.36 g/cm
3) lower than that of ISVPs (1.38 g/cm
3) (
24,
30). Recoated particles migrated at
a buoyant density
of 1.361 g/cm
3 (±0.003,
n = 3), equivalent to that of native virions, suggesting
that
stoichiometric or near-stoichiometric recoating had been
achieved.
Henceforth, we use the term rcISVPs to refer to ISVPs that have been
recoated with approximately stoichiometric levels of
baculovirus-expressed

3 protein. It is important to note that
rcISVPs are similar to virions in that they contain a full complement
of

3 but similar to ISVPs in that they contain µ1/µ1C mostly
cleaved at the

-

junction. The implications of these features
for
the structure and function of rcISVPs are addressed
below.
The
3 coats of virions and rcISVPs appear structurally
identical, as determined by electron microscopy and 3-D image
reconstruction.
rcISVPs were analyzed by conventional TEM after
negative staining to compare them to native virions and ISVPs. A
homogeneous population of particles very similar in morphology to
virions was observed (Fig. 3A). Measured
diameters of the particles ranged from 72 to 76 nm (data not shown),
which is consistent with the diameter of native virions previously
determined by negative-stain TEM (7, 24). Like virions
(24), rcISVPs displayed a smooth perimeter with
characteristic flattened edges that arise at fivefold axes where the
µl-
3 lattice is interrupted by
2 (21, 37).

View larger version (109K):
[in this window]
[in a new window]
|
FIG. 3.
Conventional TEM and cryo-SEM of rcISVPs. (A) Population
of negatively stained rcISVPs viewed by conventional TEM at a
magnification of ×100,000. Bar, 50 nm. (B) Population of
chromium-coated rcISVPs viewed by high-resolution cryo-SEM at a
magnification of ×100,000. Bar, 50 nm. (C and D) Single
chromium-coated rcISVPs viewed by cryo-SEM at a magnification of
×300,000. Particles oriented near a fivefold axis (C) and near a
twofold axis (D) are shown. Bar, 25 nm.
|
|
We used cryo-SEM to compare the organization of

3 subunits on
individual rcISVPs and virions. This technique shows individual
proteins on the surfaces of reovirus particles at a resolution
of 2 to
4 nm (
13). rcISVPs exhibited characteristic rings of
protein
distributed over much of their surface and incomplete
rings surrounding
the fivefold axes (Fig.
3B to D). These features
correspond to complete
and partial hexamers of

3 (see below),
consistent with the results
of the previous cryo-SEM study of
reovirus virions (
13). As
no clear differences distinguish the
cryo-SEM images of rcISVPs and
native virions (
13), these findings
suggest that a native

3 coat was reconstituted in
rcISVPs.
The

3 coat in rcISVPs was visualized at higher resolution in three
dimensions by using cryo-TEM techniques and image reconstruction
procedures for icosahedral particles. At 33-Å resolution, the
3-D
reconstruction revealed that rcISVPs have a capsid structure
very
similar to that of native virions (Fig.
4). The 600 finger-like
structures that
project >40 Å above the top of the µ1 protein
layer are believed to
represent 600 molecules of

3 (
21). These
projections are
arranged identically in virions (Fig.
4A and B)
and rcISVPs (Fig.
4E
and F), that is, according to T=13(laevo)
icosahedral symmetry with
complete hexamers (six

3 subunits)
surrounding the P3 channels and
partial hexamers (four

3 subunits)
forming an incomplete ring around
each P2 channel (
21,
37).
In rcISVPs as in virions, one

3
subunit in each partial hexamer
appears to form contacts with the

2
subunit(s) that projects
into the P2 channel (
21,
37). The
features attributable to

3 in the reconstruction of rcISVPs thus
confirm those observed
with individual particles by conventional TEM
and cryo-SEM and
support the conclusion that the

3 subunits in these
particles
mediate interactions with other outer-capsid proteins that
are
very similar to those in native virions.

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 4.
3-D image reconstruction of rcISVPs obtained from
cryo-TEM images (E and F; 33-Å resolution) compared with previously
reported reconstructions of T1L virions (A and B; 28-Å resolution) and
ISVPs (C and D; 29-Å resolution) (21). (A, C, and E)
Surface-shaded views down a twofold axis of symmetry for each particle.
(B, D, and F) Same views as in panels A, C, and E except that the
reconstructions were radially cropped to remove all densities below 41 nm, thereby isolating features attributable to 3 in the display.
Bar, 30 nm.
|
|
Regeneration of ISVPs from rcISVPs.
In vitro treatment of
virions with alkaline proteinases such as CHT or trypsin can remove
3 from the particle surface and cleave µ1/µ1C at the
-
junction, thus generating ISVPs (7, 30, 45). Several
observations suggest that this process is analogous to the early
proteolytic steps during reovirus infection (16, 48). To
determine if rcISVPs can be similarly processed by alkaline
proteinases, we digested purified rcISVPs under conditions of CHT
treatment designed to generate ISVPs (200 µg of CHT per ml for 20 min
at 37°C). SDS-PAGE of the reaction sample revealed that
3 was
completely removed from rcISVPs (Fig. 5)
but the remaining structural proteins were cleaved little if at all.
Treatments with trypsin gave identical results (data not shown). The
buoyant density of CHT-treated particles was measured at 1.375 g/cm3 (±0.001, n = 3), consistent with the
value of 1.38 g/cm3 characteristic of ISVPs. Hence, our
results show that ISVPs can be regenerated from rcISVPs by in vitro
treatment with alkaline proteinases and that addition and removal of
3 has little if any adverse effect on the other capsid proteins.

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 5.
Regeneration of ISVPs from rcISVPs. rcISVPs (7.5 × 1010) were treated with CHT at 200 µg/ml for 20 min at
37°C in a final volume of 20 µl. The reaction was stopped by adding
1 mM phenylmethylsulfonyl fluoride and transferring the sample to
4°C. After disruption in sample buffer, the CHT-treated sample was
analyzed by SDS-PAGE and Coomassie blue staining (lane 4), as was a
sample containing the same number of untreated rcISVPs (lane 3).
Equivalent numbers of purified virions (lane 1) and the purified ISVPs
from which the rcISVPs were generated (lane 2) were also run on the gel
for comparison.
|
|
rcISVPs are fully infectious.
Structural similarities between
rcISVPs and virions suggest that rcISVPs will provide a useful tool for
analyzing
3 structure in virions. However, meaningful studies of the
function and fate of virion-bound
3 in vivo depend on the extent to
which rcISVPs remain infectious. The relative infectivity of rcISVPs
was determined in plaque assays in which L cells were infected with
purified virions, rcISVPs, or the ISVPs that had been used to generate the rcISVP preparations. Similar determinations were made with CHT
digests of purified rcISVPs designed to regenerate ISVPs. Infectivity
was correlated with particle concentration to obtain the relative
infectivity of each preparation expressed as a particle/PFU ratio. We
found the mean relative infectivities of virions and rcISVPs to be very
similar: 74 particles/PFU for T1L virions and 70 particles/PFU for
three preparations of rcISVPs. The mean relative infectivities of the
corresponding ISVPs were also very similar: 69 particles/PFU for T1L
ISVPs and 82 particles/PFU for CHT digests of two preparations of
rcISVPs. These results indicate that neither addition of
3 to
generate rcISVPs nor its subsequent removal to regenerate ISVPs has a
substantial effect on infectivity.
Virions and rcISVPs exhibit identical replication kinetics.
There is a characteristic difference in the kinetics of viral growth
when cells are infected with reovirus virions or ISVPs. The lag phase
extends for 8 to 10 h postadsorption with virions but for only 4 to 6 h with ISVPs (3, 15, 18, 50). The absence of
3
and cleavage of µ1/µ1C at the
-
junction represent two major
structural differences between ISVPs and virions that could be related
to the different kinetics. Since rcISVPs contain
3 as do virions,
but cleaved µ1/µ1C as do ISVPs, we used them to determine whether
either of these structural features affects the lag phase in
single-cycle growth curves. Virions, rcISVPs, and ISVPs generated from
each by in vitro CHT treatment were adsorbed to L cells at 4°C, and
samples were harvested periodically over a 24-h period at 37°C for
measurement of infectious titers. Infections with virions and rcISVPs
demonstrated nearly identical growth kinetics, with the lag phase
ending near 10 h postadsorption (Fig. 6). Infections with ISVPs derived from
virions or rcISVPs also exhibited indistinguishable kinetics, but the
lag phase ended at about 4 h postadsorption (Fig. 6). Hence, the
presence or absence of
3, and not the
-
cleavage of
µ1/µ1C, appears to be the primary determinant of growth kinetics
for infections with the different particle types.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 6.
Single-step growth curve after infection with rcISVPs.
T1L virions (vir), rcISVPs (rcI), or ISVPs generated by CHT digestion
of each (vir+CHT or rcI+CHT, respectively) were used to infect L cells
at 3 PFU/cell. After 1 h at 4°C, unbound virus was removed, and
infected cells were added to 2-dram vials containing growth medium.
Infected cells were incubated at 37°C and then harvested at different
times postadsorption for determination of infectious titers by plaque
assay. The change in log10 titer over time is expressed
relative to the corresponding 0-h sample. Each point represents the
average of two independent infections.
|
|
Infections with rcISVPs are blocked by NH4Cl and E-64
but not pepstatin A.
Cells treated with inhibitors of
acid-dependent lysosomal proteinases, such as the weak base
NH4Cl and cysteine proteinase inhibitor E-64, resist
infections with reovirus virions at least in part because cleavages of
3 and/or µ1/µ1C are blocked (3, 15, 50). These
agents, however, have no effect on infections with ISVPs (3, 15,
50). The requirement for proteolysis with virions, but not ISVPs,
is thought to partially explain the different kinetics of growth after
infections with these particles. Since most µ1/µ1C molecules are
already cleaved at the
-
junction in rcISVPs, it was important to
determine whether infections with these particles are also dependent on
cleavages by the acid-dependent cysteine proteinases. Virions, rcISVPs,
and ISVPs generated from each by in vitro CHT treatment were adsorbed
to L cells at 4°C. Infections then proceeded at 37°C in the
presence or absence of 20 mM NH4Cl or 300 µM E-64, and
infectious titers were determined after 24 h. As expected,
infections with virions were blocked by NH4Cl or E-64
whereas infections with virion-derived ISVPs were not blocked by either
compound (Fig. 7A and B). Similarly, infections with rcISVPs were blocked, but infections with
rcISVP-derived ISVPs were not blocked, by either compound (Fig. 7A and
B). Thus, virions and rcISVPs, despite prior cleavage of µ1/µ1C at
the
-
junction in the latter, are similarly dependent on the
processing of
3 by acid-dependent cysteine proteinases for
productive infection.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 7.
Viral growth in the presence of NH4Cl, E-64,
or pepstatin A after infection with rcISVPs. T1L virions, rcISVP, or
their corresponding ISVPs (vir + CHT or rcI + CHT,
respectively) were used to infect L cells at 3 PFU/cell. After
attachment for 1 h at 4°C, infected cells were incubated at
37°C for 0 or 24 h in the absence ( ; open bars) or presence
(+; shaded bars) of 20 mM NH4Cl (A), 300 µM E-64 (B), or
30 µM pepstatin A (C). Infectious titers were determined by plaque
assay. The change in log10 titer after 24 h is
expressed relative to the corresponding 0-h sample. Each bar represents
the average ± standard deviation of three independent
infections.
|
|
Unlike inhibitors of acid-dependent cysteine proteinases, pepstatin A,
a specific inhibitor of aspartic proteinases like cathepsin
D, has no
effect on reovirus replication (
32). This result indicates
that degradation of

3 is a process involving a specific subset
of
cellular proteinases. To determine if aspartic proteinase activity
is
also dispensable for infections with rcISVPs, L cells were
adsorbed at
4°C with virions, rcISVPs, or CHT-generated ISVPs
from each.
Infections then proceeded at 37°C in the presence or
absence of 30 µM pepstatin A, and infectious titers were measured
at 24 h.
This inhibitor did not affect the growth of any of the
particle types
(Fig.
7C). Coupled with the NH
4Cl and E-64 results
(Fig.
7A
and B), this finding suggests that

3 in rcISVPs is susceptible
to
cleavage by the same subset of cellular proteinases as it is
in
virions.
rcISVPs cannot undergo in vitro activation to mediate hemolysis or
transcription of the viral mRNAs.
In vitro, ISVPs but not virions
can be activated to interact with lipid bilayers (9, 15, 27, 35,
39, 52) and to transcribe the viral mRNAs (8, 10, 15, 19,
22, 30, 45). Productive infection in vivo depends on analogous
activities. Available data (see above) suggest that virions require
proteolysis for infection in order to generate subvirion particles that
can undergo activation to mediate these activities. dpSVPs, which lack
3 but have most molecules of µ1/µ1C uncleaved at the
-
junction as in virions, can also be activated to interact with lipid
bilayers and to mediate transcription in vitro in the absence of
further proteolysis (15). Thus, the
-
cleavage appears to be dispensable for these activities. Because rcISVPs, in contrast to
other particles, have a full
3 coat and most µ1/µ1C molecules cleaved at the
-
junction, we used them to determine whether the
presence of
3 influences the activation of particles to mediate hemolysis and transcription.
As in preceding cell culture experiments, assays were performed with
virions, rcISVPs, and CHT-generated ISVPs from each.
CsCl was included
in samples to accelerate the structural changes
in outer-capsid
proteins that accompany membrane permeabilization
and transcriptase
activation (
8,
11,
14,
52). Lysis of
erythrocytes
(hemolysis) is believed to represent a simple model
by which the
interactions with lipid bilayers required for reovirus
entry into cells
can be investigated (
15,
39). Hemolysis assays
performed in
this study indicate that ISVPs but not virions or
rcISVPs can be
activated to interact with lipid bilayers (Fig.
8). Activation of the viral transcriptase
is thought to require
changes in particle structure that follow and/or
accompany membrane
permeabilization (
10,
14,
19,
21,
22,
27,
30,
39).
Transcriptase assays performed in this study indicate that
ISVPs
but not virions or rcISVPs can be activated to produce viral
transcripts
(Fig.
8). Taken together, the hemolysis and transcription
results
suggest that the presence or absence of

3 protein, and not
the

-

cleavage of µ1/µ1C, is the primary determinant of
whether
a given particle type can be activated to interact with lipid
bilayers and to transcribe the viral mRNAs.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 8.
Capacity of rcISVPs to be activated to mediate hemolysis
or transcription. Each bar represents the mean ± standard
deviation from three trials. (A) A 3% solution of calf erythrocytes
was incubated with 5 × 1010 T1L virions (vir),
rcISVPs (rcI), or ISVPs generated by CHT digestion of each (vir + CHT or rcI + CHT, respectively) at 37°C for 30 min in the
presence of 200 mM CsCl as an accelerant (8, 15). The extent
of hemolysis was expressed as a percentage of that obtained by
hypotonic lysis. (B) T1L virions, rcISVPs, or their respective ISVPs
(5 × 1010 each) were incubated with a transcription
mixture including 2 mM ribonucleoside triphosphate, 1.13 µCi of
[ -32P]GTP, and 200 mM CsCl. The incorporation of
32P into viral transcripts was measured after precipitation
with trichloroacetic acid (36).
|
|
rcISVPs and virions are similarly thermostable.
Reovirus
virions are more resistant to heat inactivation than ISVPs
(44). This property may enable virions to survive a wider
range of conditions outside host organisms, thereby improving transmission of the virus between hosts (41). rcISVPs were
analyzed to distinguish the roles of
3 and cleavage of µ1/µ1C at
the
-
junction in determining the thermostability of particles.
Virions, rcISVPs and ISVPs derived from each by in vitro CHT treatment were incubated at either 52 or 4°C in virion buffer for 1 h, and samples were then assayed for infectivity (Fig.
9). After 1 h at 52°C, ISVP
samples exhibited a large decrease in titer, to <0.01% of that of the
4°C controls. In contrast, the titers of virions and rcISVPs
decreased only to ~10% of control levels. Thus, virions and rcISVPs
exhibited comparable greater thermostability than their respective
ISVPs. The CHT present in the ISVP samples was not responsible for the
loss of infectivity observed with heating since inactivation
experiments performed with purified T1L ISVPs, with or without added
CHT, gave very similar results (reference 44 and
data not shown). These results demonstrate that
3 is the primary
determinant of the different thermostabilities of virions and ISVPs and
that cleavage of µ1/µ1C at the
-
junction has little or no
effect on this property. These conclusions are consistent with a
previous analysis showing that the S4 gene (which encodes
3)
determines strain-specific differences in the thermostability of
reovirus virions (20).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 9.
Sensitivity of rcISVPs to heat inactivation. T1L virions
(vir), rcISVPs (rcI), or ISVPs generated by CHT digestion of each
(vir + CHT or rcI + CHT, respectively) were subjected to heat
inactivation at 52°C for 1 h. Corresponding samples were kept at
4°C as controls. Infectious titers were determined by plaque assay,
and the change in log10 titer with heat treatment is
expressed relative to the corresponding 4°C sample. Each bar
represents the mean ± standard deviation from three trials.
|
|
Analysis of
3 cleavage rate by recoating genetics using chimeric
3 proteins bound to ISVPs.
Proteolysis of reovirus outer-capsid
proteins by luminal alkaline proteinases in the mammalian small
intestine is required for at least some reovirus strains to adhere to M
cells and infect intestinal target tissues (1, 6). During
the course of experiments to dissect the cascade of cleavages that
occur during alkaline proteolysis of
3, we treated purified T1L and
T3D virions in vitro with endoproteinase Lys-C (EKC), a serine alkaline
proteinase, and observed a difference in the rate at which full-length
3 protein was cleaved in these two strains, the
3 protein in T1L virions being cleaved faster than that in T3D virions (29). A genetic analysis using T1L × T3D reassortants indicated that the determinants of this difference reside within the two
3 proteins themselves (29). To localize these determinants within
3,
we took advantage of our method for recoating ISVPs with
baculovirus-expressed
3 protein. Eight distinct types of
[35S]methionine/cysteine-labeled
3 protein were
separately expressed and used for recoating T1L ISVPs: T1L
3, T3D
3, and six chimeric proteins generated by exchanging amino acids 1 to 185, 186 to 265, and/or 266 to 365 between the T1L and T3D
3
proteins (Fig. 10A). The resulting
particles were purified from CsCl gradients and subjected to EKC
cleavage, followed by visualization and quantitation of full-length
3 protein by SDS-PAGE and phosphorimaging (Fig. 10B). The extent of
3 cleavage was assessed by comparing the intensities of the
full-length
3 bands from EKC-treated and untreated samples of each
particle preparation (Fig. 10C). The results demonstrate that the
C-terminal 100 amino acids of
3 contain the primary determinants of
the different rates of EKC cleavage of T1L and T3D
3: all
3
proteins with the C-terminal region from T1L exhibited a higher rate of
cleavage than those with the C-terminal region from T3D (Fig. 10C).
Interestingly, the N-terminal and middle regions of
3 made secondary
contributions to cleavage rate, but in the directions opposite those
expected from behaviors of the parental proteins: chimeric
3
proteins containing the N-terminal and/or middle regions from T3D
exhibited an increased rate of cleavage, whereas chimeric
3 proteins
containing one or both of those regions from T1L exhibited a decreased
rate of cleavage. These findings suggest that different regions of
3
can contribute to the overall rate of cleavage but indicate a more
prominent role for C-terminal sequences. The latter conclusion concurs
with that from another recent study, which showed that a mutation near
the C terminus of
3 affects the proteinase sensitivity of the
virion-bound protein in a reovirus mutant selected during persistent
infection (55).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 10.
Analysis of 3 cleavage rate by recoating genetics
using chimeric 3 proteins bound to ISVPs. (A) T1L and T3D 3
proteins, as well as six 3 chimeras generated by exchanging
N-terminal, middle, and C-terminal regions (junctions indicated by
amino acid number) of the 3 proteins of reoviruses T1L and T3D, were
expressed in insect cells (see Materials and Methods). Each type of
3 protein is designated by three letters indicating the origin (L or
D) of the three regions. (B)
[35S]methionine/cysteine-labeled 3 proteins of the
eight types shown in panel A were separately bound to T1L ISVPs, which
were then purified in a CsCl gradient and dialyzed into virion buffer.
The purified particles were subsequently treated with EKC (20 µg/ml)
for 1 h at 37°C, and the reaction was stopped using 1 mM TLCK
(Sigma). Equivalent numbers of EKC-treated (+) and untreated ( )
particles were analyzed by SDS-PAGE and phosphorimaging. The bands
corresponding to full-length 3 are shown from two representative
gels on which all eight types of 3-containing particles were
analyzed. (C) The 3 bands were quantitated by phosphorimaging, and
the amount of full-length 3 remaining in each EKC-treated sample was
expressed as a percentage of that in the corresponding untreated
sample. The filled and open bars indicate measurements from two pairs
of samples for each particle preparation.
|
|
 |
DISCUSSION |
Assembly of
3 into virions in vivo and in vitro.
In
reovirus-infected cells, mature virions undergo a regulated process of
assembly that remains poorly characterized. One observation, however,
is that outer-capsid assembly is blocked and core-like particles
accumulate when cells are infected at nonpermissive temperatures with
virus containing a temperature-sensitive lesion in the S4 gene
(tsG453) (38, 47). This finding suggests that the
µ1 protein cannot be assembled into particles in the absence of
functional
3. In fact, µ1 and
3 are known to form complexes in
solution (33), and this interaction modifies the conformation of
3 such that its proteinase sensitivity is increased to the level seen in virions (46). In addition, the µ1
protein in µ1-
3 complexes becomes susceptible to cleavage near its
N terminus, yielding fragments µ1N and µ1C through what is thought to be an autocatalytic mechanism (42, 51). Together, these findings suggest that during assembly of virions in infected cells, µ1-
3 complexes are formed first, which modifies the conformation of both µ1 and
3 and allows these complexes to bind to nascent particles (38, 47).
The procedure for generating rcISVPs described in this study involves a
mechanism for

3 assembly into particles distinct
from that observed
in vivo. In our in vitro system, an apparently
native

3 coat is
reconstituted in rcISVPs after soluble

3 binds
to the preformed µ1
lattice in ISVPs. Hence,

3 does not strictly
require the prior
formation of µ1-

3 complexes for assembly into
particles. Given
this fact, we infer that the necessity for forming
µ1-

3 complexes
before assembly onto core-like particles in infected
cells most likely
reflects the need for

3 binding to induce µ1
into a specific
conformation that is competent to self-associate
or to interact with
other viral components in forming the outer
capsid. The mechanism for
assembling

3 onto ISVPs, which we have
exploited, is also
demonstrated by ISVP-like particles from cellular
lysosomes when they
undergo recoating with soluble

3 from the
cytoplasm or nucleus upon
disruption of reovirus-infected cells
(
2,
16,
50).
Binding to
3 is not blocked by cleavages of µ1 at the
µ1N-µ1C and
-
junctions in ISVPs.
As noted above, the
µ1 molecules in virions have undergone several changes in structure
relative to soluble µ1, including conformational changes and a
cleavage near their N termini to generate the µ1N and µ1C fragments
by which most µ1 molecules are represented in virions. Moreover, when
ISVPs are subsequently generated from virions by proteolysis, the
µ1/µ1C molecules undergo an additional cleavage near their C
termini to generate fragments µ1
/
and
(40). It
was conceivable that one or more of these changes might have modified
µ1 such that, in its ISVP-bound form, it was no longer competent to
bind soluble
3 protein. However, because soluble
3 can bind to
µ1
/
and/or
in ISVPs, as directly shown in this study and
previously (2, 46), the sites in µ1 that mediate
3
binding cannot have been irreversibly modified as a consequence of any
of the changes in µ1 that accompany complex formation, µ1N-µ1C
cleavage, particle binding, or
-
cleavage. In partial support of
this conclusion, a 3-D reconstruction of dpSVPs, in which very few
µ1/µ1C molecules have been cleaved at the
-
junction
(15), failed to demonstrate any clear structural differences
from ISVPs (54), suggesting that the
-
cleavage in
ISVPs has little effect on µ1 conformation.
Effect of
3 on functional properties of reovirus particles in
vitro and in vivo.
After addition of
3 to ISVPs, to generate
rcISVPs, these particles behave like virions in all of the functional
properties tested in this study (summarized in Table
2). Thus,
3 is a key determinant of
particle behavior for each of these properties. An important structural
distinction between virions and rcISVPs is that the latter contain most
molecules of µ1/µ1C cleaved at the
-
junction, like ISVPs. As
a result, our findings with rcISVPs also indicate that cleavage of
µ1/µ1C at the
-
junction is not an important determinant of
the differences in behavior between virions and ISVPs studied here.
Previous experiments with dpSVPs, a distinct type of subvirion particle
that lacks
3 but contains most molecules of µ1/µ1C still
uncleaved at the
-
junction, provided support for this conclusion
by showing that dpSVPs behave like ISVPs in a similar set of tested
properties (15) (summarized in Table 2), despite the low
level of
-
cleavage in dpSVPs. The analyses of rcISVPs here and
of dpSVPs in the previous study (15) are thus consistent and
complementary in demonstrating the key role of
3 and the negligible
role of
-
cleavage in determining the different particle
behaviors.
Although we have clearly shown that

3 affects the behavior of
particles in several in vitro and in vivo assays, we have yet
to define
the molecular mechanisms by which

3 exerts its effects.
It appears
likely that the presence of

3 in particles inhibits
one or more of
the other capsid proteins from completing their
function or functions
in reovirus entry. Thus, when

3 remains
present after receptor
binding and uptake by cells, as in infections
with virions and rcISVPs,
it must be cleaved by a cellular proteinase
or proteinases to eliminate
this inhibitory effect. Since activation
to interact with membrane
bilayers and to transcribe the viral
mRNAs involves conformational
changes in the outer capsid (
8,
10,
14,
19,
22,
27,
30,
39),
our current hypothesis
is that

3 acts primarily by limiting the
conformational mobility
of the relevant protein or proteins. Since

3
has extensive interactions
with µ1 in the virion outer capsid
(
21), and since µ1 has roles
in membrane penetration and
transcriptase activation, the effects
of

3 most likely occur through
its interactions with µ1. Nonetheless,
effects of

3 on

2 or

1, the other two outer capsid proteins,
are also conceivable.
Potential effects of

3 on

1 structure
and functions in rcISVPs
are a focus of current
studies.
rcISVPs as reagents for mutational studies of
3.
The lack
of an effective method for engineering mutations into the genomes of
double-stranded RNA viruses in the family Reoviridae has
hindered studies of various aspects of their biochemistry and biology.
Our new method for recoating ISVPs, however, represents a simple yet
effective system that can overcome this limitation in a partial way for
the reovirus
3 protein. By engineering selected mutations into an S4
cDNA clone, expressing mutant forms of recombinant
3 protein, and
using these mutant
3 molecules to generate rcISVPs (29),
we can now perform detailed characterizations of the effects of these
mutations, both in vitro and in vivo, on the properties of
3
relating to reovirus entry. A notable advantage of this system is that
it does not rely on viral replication for recovery of infectious
virions containing the mutant
3 proteins. Thus, mutations that may
have lethal effects on infection, and would be difficult or even
impossible to amplify by using a more classical reverse-genetic
approach, can be readily studied with our approach. The genetic
analysis of
3 cleavage rate included in this study provides a
concrete demonstration of the utility of the recoating approach as a
genetic tool and also demonstrates how chimeric proteins constructed to
have different regions derived from different virus strains can be used
in localizing the sequence determinants of strain-dependent differences
in the behaviors of particle-bound proteins.
 |
ACKNOWLEDGMENTS |
We thank S. J. Harrison, J. J. Lugus, and X.-H. Zhou
for excellent technical help and the other members of our laboratories for helpful discussions. We also thank K. Chandran, G. A. Manji, and S. A. Rice for insightful comments on preliminary versions of
the manuscript.
This work was supported by NIH research grants AI-39533 (to M.L.N.),
GM-33050 and AI-35212 (to T.S.B.), and AI-32139 (to L.A.S.); DARPA
research contract MDA 972-97-1-0005 (to M.L.N.); research grants from
the Lucille P. Markey Charitable Trust (to the Institute for Molecular
Virology, University of Wisconsin
Madison, and the Structural Biology
Center, Purdue University); NIH research technology grant RR-00570 (to
the Integrated Microscopy Resource, University of Wisconsin
Madison);
and American Cancer Society research grant RPG-98-12701-MBC (to
L.A.S.). J.J.-V. was supported by a fellowship from La Caixa
d'Estalvis i Pensions de Barcelona and by a Steenbock fellowship from
the Department of Biochemistry, University of Wisconsin
Madison.
M.L.N. received additional support as a Shaw Scientist from the
Milwaukee Foundation. S.B.W. was supported by a Purdue Biophysics
training grant and a Purdue Research Foundation fellowship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute for
Molecular Virology, University of Wisconsin
Madison, 1525 Linden Dr., Madison, WI 53706. Phone: (608) 262-4536. Fax: (608) 262-7414. E-mail:
mlnibert{at}facstaff.wisc.edu.
 |
REFERENCES |
| 1.
|
Amerongen, H. M.,
G. A. R. Wilson,
B. N. Fields, and M. R. Neutra.
1994.
Proteolytic processing of reovirus is required for adherence to intestinal M cells.
J. Virol.
68:8428-8432[Abstract/Free Full Text].
|
| 2.
|
Astell, C.,
S. C. Silverstein,
D. H. Levin, and G. Acs.
1972.
Regulation of the reovirus RNA transcriptase by a viral capsomere protein.
Virology
48:648-654[Medline].
|
| 3.
|
Baer, G. S., and T. S. Dermody.
1997.
Mutations in reovirus outer-capsid protein 3 selected during persistent infections of L cells confer resistance to protease inhibitor E64.
J. Virol.
71:4921-4928[Abstract].
|
| 4.
|
Baker, T. S., and R. H. Cheng.
1996.
A model-based approach for determining orientations of biological macromolecules imaged by cryoelectron microscopy.
J. Struct. Biol.
116:120-130[Medline].
|
| 5.
|
Baker, T. S.,
J. Drak, and M. Bina.
1988.
Reconstruction of the three-dimensional structure of simian virus 40 and visualization of the chromatin core.
Proc. Natl. Acad. Sci. USA
85:422-426[Abstract/Free Full Text].
|
| 6.
|
Bodkin, D. K.,
M. L. Nibert, and B. N. Fields.
1989.
Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice.
J. Virol.
63:4676-4681[Abstract/Free Full Text].
|
| 7.
|
Borsa, J.,
T. P. Copps,
M. D. Sargent,
D. G. Long, and J. D. Chapman.
1973.
New intermediate subviral particles in the in vitro uncoating of reovirus virions by chymotrypsin.
J. Virol.
11:552-564[Abstract/Free Full Text].
|
| 8.
|
Borsa, J.,
D. G. Long,
T. P. Copps,
M. D. Sargent, and J. D. Chapman.
1974.
Reovirus transcriptase activation in vitro: further studies on the facilitation phenomenon.
Intervirology
3:15-35[Medline].
|
| 9.
|
Borsa, J.,
B. D. Morash,
M. D. Sargent,
T. P. Copps,
P. A. Lievaart, and J. G. Szekely.
1979.
Two modes of entry of reovirus particles into L cells.
J. Gen. Virol.
45:161-170[Abstract/Free Full Text].
|
| 10.
|
Borsa, J.,
M. D. Sargent,
P. A. Lievaart, and T. P. Copps.
1981.
Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process.
Virology
111:191-200[Medline].
|
| 11.
|
Borsa, J.,
M. D. Sargent,
D. G. Long, and J. D. Chapman.
1973.
Extraordinary effects of specific monovalent cations on activation of reovirus transcriptase by chymotrypsin in vitro.
J. Virol.
11:207-217[Abstract/Free Full Text].
|
| 12.
|
Canning, W. M., and B. N. Fields.
1983.
Ammonium chloride prevents lytic growth of reovirus and helps to establish persistent infection in mouse L cells.
Science
219:987-988[Abstract/Free Full Text].
|
| 13.
|
Centonze, V. E.,
Y. Chen,
T. F. Severson,
G. G. Borisy, and M. L. Nibert.
1995.
Visualization of individual reovirus particles by low-temperature, high-resolution scanning microscopy.
J. Struct. Biol.
115:215-225[Medline].
|
| 14.
| Chandran, K., D. L. Farsetta, and M. L. Nibert. Unpublished data.
|
| 15.
|
Chandran, K., and M. L. Nibert.
1998.
Protease cleavage of reovirus capsid protein µ1/µ1C is blocked by alkyl sulfate detergents, yielding a new type of infectious subvirion particle.
J. Virol.
72:467-475[Abstract/Free Full Text].
|
| 16.
|
Chang, C.-T., and H. J. Zweerink.
1971.
Fate of parental reovirus in infected cell.
Virology
46:544-555[Medline].
|
| 17.
|
Coombs, K. M.
1998.
Stoichiometry of reovirus structural proteins in virus, ISVP, and core particles.
Virology
243:218-228[Medline].
|
| 18.
|
Cox, D. C., and W. Clinkscales.
1976.
Infectious reovirus subviral particles: virus replication, cellular cytopathology, and DNA synthesis.
Virology
74:259-261[Medline].
|
| 19.
|
Drayna, D., and B. N. Fields.
1982.
Activation and characterization of the reovirus transcriptase: genetic analysis.
J. Virol.
41:110-118[Abstract/Free Full Text].
|
| 20.
|
Drayna, D., and B. N. Fields.
1982.
Genetic studies on the mechanism of chemical and physical inactivation of reovirus.
J. Gen. Virol.
63:149-159[Abstract/Free Full Text].
|
| 21.
|
Dryden, K. A.,
G. Wang,
M. Yeager,
M. L. Nibert,
K. M. Coombs,
D. B. Furlong,
B. N. Fields, and T. S. Baker.
1993.
Early steps in reovirus infection are associated with dramatic changes in supramolecular structure and protein conformation: analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction.
J. Cell Biol.
122:1023-1041[Abstract/Free Full Text].
|
| 22.
|
Ewing, D. D.,
M. D. Sargent, and J. Borsa.
1985.
Switch-on of transcriptase function in reovirus: analysis of polypeptide changes using 2-D gels.
Virology
144:448-456[Medline].
|
| 23.
|
Fuller, S. D.,
S. J. Butcher,
R. H. Cheng, and T. S. Baker.
1996.
Three-dimensional reconstruction of icosahedral particles the uncommon line.
J. Struct. Biol.
116:45-55.
|
| 24.
|
Furlong, D. B.,
M. L. Nibert, and B. N. Fields.
1988.
Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles.
J. Virol.
62:246-256[Abstract/Free Full Text].
|
| 25.
|
Gillian, A. L., and M. L. Nibert.
1998.
Amino terminus of reovirus nonstructural protein NS is important for ssRNA binding and nucleoprotein complex formation.
Virology
240:1-11[Medline].
|
| 26.
|
Hayes, E. C.,
P. W. K. Lee,
S. E. Miller, and W. K. Joklik.
1981.
The interaction of a series of hybridoma IgGs with reovirus particles. Demonstration that the core protein 2 is exposed on the particle surface.
Virology
108:147-155[Medline].
|
| 27.
|
Hooper, J. W., and B. N. Fields.
1996.
Role of the µ1 protein in reovirus stability and capacity to cause chromium release from host cells.
J. Virol.
70:459-467[Abstract].
|
| 28.
| Jané-Valbuena, J., G. A. Manji, P. D. Friesen, and M. L. Nibert. Unpublished data.
|
| 29.
| Jané-Valbuena, J., S. Yue, L. A. Schiff, and
M. L. Nibert. Unpublished data.
|
| 30.
|
Joklik, W. K.
1972.
Studies on the effect of chymotrypsin on reovirions.
Virology
49:700-715[Medline].
|
| 31.
|
Kedl, R.,
S. Schmechel, and L. Schiff.
1995.
Comparative sequence analysis of the reovirus S4 genes from 13 serotype 1 and serotype 3 field isolates.
J. Virol.
69:552-559[Abstract].
|
| 32.
|
Kothandaraman, S.,
M. C. Hebert,
R. T. Raines, and M. L. Nibert.
1998.
No role for pepstatin A-sensitive proteinases in reovirus infections of L or MDCK cells.
Virology
251:264-272[Medline].
|
| 33.
|
Lee, P. W. K.,
E. C. Hayes, and W. K. Joklik.
1981.
Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines.
Virology
108:134-146[Medline].
|
| 34.
|
Lerch, R. A., and P. D. Friesen.
1993.
The 35-kilodalton protein gene (p35) of Autographa californica nuclear polyhedrosis virus and the neomycin resistance gene provide dominant selection of recombinant baculoviruses.
Nucleic Acids Res.
21:1753-1760[Abstract/Free Full Text].
|
| 35.
|
Lucia-Jandris, P.,
J. W. Hooper, and B. N. Fields.
1993.
Reovirus M2 gene is associated with chromium release from mouse L cells.
J. Virol.
67:5339-5345[Abstract/Free Full Text].
|
| 36.
|
Luongo, C. L.,
K. A. Dryden,
D. L. Farsetta,
R. L. Margraf,
T. F. Severson,
N. H. Olson,
B. N. Fields,
T. S. Baker, and M. L. Nibert.
1997.
Localization of a C-terminal region of 2 protein in reovirus cores.
J. Virol.
71:8035-8040[Abstract].
|
| 37.
|
Metcalf, P.,
M. Cyrklaff, and M. Adrian.
1991.
The three-dimensional structure of reovirus obtained by cryo-electron microscopy.
EMBO J.
10:3129-3136[Medline].
|
| 38.
|
Morgan, E. M., and H. J. Zweerink.
1974.
Reovirus morphogenesis. Corelike particles in cells infected at 39° with wild-type reovirus and temperature-sensitive mutants of groups B and G.
Virology
59:556-565[Medline].
|
| 39.
|
Nibert, M. L.
1993.
Structure and function of reovirus outer-capsid proteins as they relate to early steps in infection. Ph.D. thesis.
Harvard University, Cambridge, Mass.
|
| 40.
|
Nibert, M. L., and B. N. Fields.
1992.
A carboxy-terminal fragment of protein µ1/µ1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration.
J. Virol.
66:6408-6418[Abstract/Free Full Text].
|
| 41.
|
Nibert, M. L.,
D. B. Furlong, and B. N. Fields.
1991.
Mechanisms of viral pathogenesis. Distinct forms of reoviruses and their roles during replication in cells and host.
J. Clin. Investig.
88:727-734.
|
| 42.
|
Nibert, M. L.,
L. A. Schiff, and B. N. Fields.
1991.
Mammalian reoviruses contain a myristoylated structural protein.
J. Virol.
65:1960-1967[Abstract/Free Full Text].
|
| 43.
|
Schmechel, S.,
M. Chute,
P. Skinner,
R. Anderson, and L. Schiff.
1997.
Preferential translation of reovirus mRNA by a 3-dependent mechanism.
Virology
232:62-73[Medline].
|
| 44.
| Severson, T. F., K. Chandran, A. L. Gillian,
and M. L. Nibert. Unpublished data.
|
| 45.
|
Shatkin, A. J., and A. J. LaFiandra.
1972.
Transcription by infectious subviral particles of reovirus.
J. Virol.
10:698-706[Abstract/Free Full Text].
|
| 46.
|
Shepard, D. A.,
J. G. Ehnstrom, and L. A. Schiff.
1995.
Association of reovirus outer capsid proteins 3 and µ1 causes a conformational change that renders 3 protease sensitive.
J. Virol.
69:8180-8184[Abstract].
|
| 47.
|
Shing, M., and K. M. Coombs.
1996.
Assembly of the reovirus outer capsid requires µ1/ 3 interactions which are prevented by misfolded 3 protein in temperature-sensitive mutant tsG453.
Virus Res.
46:19-29[Medline].
|
| 48.
|
Silverstein, S. C.,
M. Schonberg,
D. H. Levin, and G. Acs.
1970.
The reovirus replicative cycle: conservation of parental RNA and protein.
Proc. Natl. Acad. Sci. USA
67:275-281[Abstract/Free Full Text].
|
| 49.
|
Strong, J. E.,
G. Leone,
R. Duncan,
R. K. Sharma, and P. W. K. Lee.
1991.
Biochemical and biophysical characterization of the reovirus cell attachment protein 1: evidence that it is a homotrimer.
Virology
184:23-32[Medline].
|
| 50.
|
Sturzenbecker, L. J.,
M. Nibert,
D. Furlong, and B. N. Fields.
1987.
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle.
J. Virol.
61:2351-2361[Abstract/Free Full Text].
|
| 51.
|
Tillotson, L., and A. J. Shatkin.
1992.
Reovirus polypeptide 3 and N-terminal myristoylation of polypeptide µ1 are required for site-specific cleavage to µ1C in transfected cells.
J. Virol.
66:2180-2186[Abstract/Free Full Text].
|
| 52.
|
Tosteson, M. T.,
M. L. Nibert, and B. N. Fields.
1993.
Ion channels induced in lipid bilayers by subvirion particles of the nonenveloped mammalian reoviruses.
Proc. Natl. Acad. Sci. USA
90:10549-10552[Abstract/Free Full Text].
|
| 53.
|
Virgin, H. W., IV,
M. A. Mann,
B. N. Fields, and K. L. Tyler.
1991.
Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action.
J. Virol.
65:6772-6781[Abstract/Free Full Text].
|
| 54.
| Walker, S. B., K. Chandran, M. L. Nibert, and
T. S. Baker. Unpublished data.
|
| 55.
|
Wetzel, J. D.,
G. J. Wilson,
G. S. Baer,
L. R. Dunnigan,
J. P. Wright,
D. S. H. Tang, and T. S. Dermody.
1997.
Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly.
J. Virol.
71:1362-1369[Abstract].
|
| 56.
|
Yue, Z., and A. J. Shatkin.
1996.
Regulated, stable expression and nuclear presence of reovirus double-stranded RNA-binding protein 3 in HeLa cells.
J. Virol.
70:3497-3501[Abstract].
|
Journal of Virology, April 1999, p. 2963-2973, Vol. 73, No. 4
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Clark, K. M., Wetzel, J. D., Gu, Y., Ebert, D. H., McAbee, S. A., Stoneman, E. K., Baer, G. S., Zhu, Y., Wilson, G. J., Prasad, B. V. V., Dermody, T. S.
(2006). Reovirus Variants Selected for Resistance to Ammonium Chloride Have Mutations in Viral Outer-Capsid Protein {sigma}3. J. Virol.
80: 671-681
[Abstract]
[Full Text]
-
Helander, A., Miller, C. L., Myers, K. S., Neutra, M. R., Nibert, M. L.
(2004). Protective Immunoglobulin A and G Antibodies Bind to Overlapping Intersubunit Epitopes in the Head Domain of Type 1 Reovirus Adhesin {sigma}1. J. Virol.
78: 10695-10705
[Abstract]
[Full Text]
-
Golden, J. W., Bahe, J. A., Lucas, W. T., Nibert, M. L., Schiff, L. A.
(2004). Cathepsin S Supports Acid-independent Infection by Some Reoviruses. J. Biol. Chem.
279: 8547-8557
[Abstract]
[Full Text]
-
Odegard, A. L., Chandran, K., Liemann, S., Harrison, S. C., Nibert, M. L.
(2003). Disulfide Bonding among {micro}1 Trimers in Mammalian Reovirus Outer Capsid: a Late and Reversible Step in Virion Morphogenesis. J. Virol.
77: 5389-5400
[Abstract]
[Full Text]
-
Wilson, G. J., Nason, E. L., Hardy, C. S., Ebert, D. H., Wetzel, J. D., Venkataram Prasad, B. V., Dermody, T. S.
(2002). A Single Mutation in the Carboxy Terminus of Reovirus Outer-Capsid Protein {sigma}3 Confers Enhanced Kinetics of {sigma}3 Proteolysis, Resistance to Inhibitors of Viral Disassembly, and Alterations in {sigma}3 Structure. J. Virol.
76: 9832-9843
[Abstract]
[Full Text]
-
Chandran, K., Farsetta, D. L., Nibert, M. L.
(2002). Strategy for Nonenveloped Virus Entry: a Hydrophobic Conformer of the Reovirus Membrane Penetration Protein {micro}1 Mediates Membrane Disruption. J. Virol.
76: 9920-9933
[Abstract]
[Full Text]
-
Ebert, D. H., Deussing, J., Peters, C., Dermody, T. S.
(2002). Cathepsin L and Cathepsin B Mediate Reovirus Disassembly in Murine Fibroblast Cells. J. Biol. Chem.
277: 24609-24617
[Abstract]
[Full Text]
-
Golden, J. W., Linke, J., Schmechel, S., Thoemke, K., Schiff, L. A.
(2002). Addition of Exogenous Protease Facilitates Reovirus Infection in Many Restrictive Cells. J. Virol.
76: 7430-7443
[Abstract]
[Full Text]
-
Jane-Valbuena, J., Breun, L. A., Schiff, L. A., Nibert, M. L.
(2002). Sites and Determinants of Early Cleavages in the Proteolytic Processing Pathway of Reovirus Surface Protein {sigma}3. J. Virol.
76: 5184-5197
[Abstract]
[Full Text]
-
Middleton, J. K., Severson, T. F., Chandran, K., Gillian, A. L., Yin, J., Nibert, M. L.
(2002). Thermostability of Reovirus Disassembly Intermediates (ISVPs) Correlates with Genetic, Biochemical, and Thermodynamic Properties of Major Surface Protein {micro}1. J. Virol.
76: 1051-1061
[Abstract]
[Full Text]
-
Chandran, K., Zhang, X., Olson, N. H., Walker, S. B., Chappell, J. D., Dermody, T. S., Baker, T. S., Nibert, M. L.
(2001). Complete In Vitro Assembly of the Reovirus Outer Capsid Produces Highly Infectious Particles Suitable for Genetic Studies of the Receptor-Binding Protein. J. Virol.
75: 5335-5342
[Abstract]
[Full Text]
-
Ebert, D. H., Wetzel, J. D., Brumbaugh, D. E., Chance, S. R., Stobie, L. E., Baer, G. S., Dermody, T. S.
(2001). Adaptation of Reovirus to Growth in the Presence of Protease Inhibitor E64 Segregates with a Mutation in the Carboxy Terminus of Viral Outer-Capsid Protein {sigma}3. J. Virol.
75: 3197-3206
[Abstract]
[Full Text]
-
Baker, T. S., Olson, N. H., Fuller, S. D.
(1999). Adding the Third Dimension to Virus Life Cycles: Three-Dimensional Reconstruction of Icosahedral Viruses from Cryo-Electron Micrographs. Microbiol. Mol. Biol. Rev.
63: 862-922
[Abstract]
[Full Text]
-
Chandran, K., Walker, S. B., Chen, Y., Contreras, C. M., Schiff, L. A., Baker, T. S., Nibert, M. L.
(1999). In Vitro Recoating of Reovirus Cores with Baculovirus-Expressed Outer-Capsid Proteins µ1 and sigma 3. J. Virol.
73: 3941-3950
[Abstract]
[Full Text]